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Characterization of a Developmental
Toxicity Dose-Response Model
by Elaine M. Faustman,* Dorothy G. Wellington,t
William P. Smith,t and Carole A. Kimmelf
The Rai and Van Ryzin dose-response model proposed for teratology experiments has been
characterized for its appropriateness and applicability in modeling the dichotomous response data
from developmental toxicity studies. Modifications were made in the initial probability statements to
reflect more accurately biological events underlying developmental toxicity. Data sets used for the
evaluation were obtained from the National Toxicology Program and U.S. EPA laboratories. The
studies included developmental evaluations of ethylene glycol, diethylhexyl phthalate, di- and
triethylene glycol dimethyl ethers, and nitrofen in rats, mice, or rabbits. Graphic examination and
statistical evaluation demonstrate that this model is sensitive to the data when compared to directly
measured experimental outcomes. The model was used to interpolate to low-risk dose levels, and
comparisons were made between the values obtained and the no-observed-adverse-effect levels
(NOAELs) divided by an uncertainty factor. Our investigation suggests that the Rai and Van Ryzin
model is sensitive to the developmental toxicity end points, prenatal deaths, and malformations, and
appears to model closely their relationship to dose.
Introduction
Current methodology for quantitative develop-
mental toxicity risk assessment is based on the
identification of no-observed-adverse-effect levels
(NOAELs) and the application of uncertainty factors
(UFs) to them. Other articles in this issue discuss the
problems and limitations inherent in this approach
(1,2). In particular, emphasizing a single dose level, the
NOAEL, to set regulatory target doses ignores most of
the information on the relationship between dose and
response and does not take into account the variability
inherent in the data. This article presents the authors'
initial efforts to characterize and modify a dose-
response model that has been proposed as an alternate
approach to current risk assessment in developmental
toxicity.
Since models of carcinogenic risk cannot be used for
data from developmental toxicity studies because they
do not allow for the relatedness or nonindependence of
observations from the same litter, new modeling
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approaches are needed that take these points into
consideration. In particular, theoretical mathematical
models are needed to provide estimates of risk levels at
specified low doses and estimates of doses at specified
low levels of risk that are not strongly dependent upon
the choice of the lowest dose administered in a study
and to provide estimates for which confidence
(uncertainty) statements can be made.
A model proposed in 1985 by Rai and Van Ryzin (3)
for characterizing dose response for dichotomous data
in teratology studies was chosen for investigation
because of its potential for adaptation and extension to
reflect simple mechanistic aspects of the underlying
biologic processes. This model can be described as atwo-
stage probability model with flexible distributional
assumptions. The model was designed to estimate the
probability of teratological outcomes for individual
fetuses. However, as originally proposed, the proba-
bility statements assumed teratogenicity contingent
on maternal toxicity. Moreover, the data that were used
to demonstrate the model application were from a
dominant lethal study in which males were exposed to
X-irradiation prior to mating. In the present paper, the
model probability statements are reinterpreted to fit the
typical developmental toxicity study with exposure to
the dam during the period of major organogenesis
and evaluation of the offspring at term. The model was
characterized using data from developmental toxicity
studies conducted by the National ToxicologyFAUSTMAN ETAL.
Program and the U.S. EPA Health Effects Research
Laboratory.
Model Description
Basically, the Rai and Van Ryzin (RVR) model is
the product of two component probabilities-the first
unconditional and the second conditional upon the
first-that represent two related stages in the develop-
ment of an adverse developmental effect (response)
under study. The model estimates the probability that
an individual fetus from a litter of specified size s,
whose dam was exposed during the appropriate period
to dose d, will exhibit the response of interest. The
relatedness within litters (intralitter correlation) that
is due to having the same dam is addressed by an effort
to account for the variability among dams (litters) in
the same dose group. This interdam or interlitter
variability is represented by a variable for litter size,
which is included in the second probability compo-
nent of the model, structured upon the assumption
that larger litter size indicates a healthier dam and
hence a lower risk to the individual fetus.
Expression of the RVR model has been extended to
the following general form:
Probability ofeffect on fetus =
Probability ofeffect
on litter environment
Probability ofeffect
X on fetus conditional
on littereffect
or P(d,s) = X(d) X P[d,s;X(d)]
[1i
where P (d,s) is the probability of an adverse develop-
mental effect on a fetus from a litter of size s, whose dam
was exposed to dose d; X (d) is the probability of a
predisposing change (disturbance) in the litter
environment; and P[d,s; k(d)] is the conditional
probability of an adverse developmental effect on a fetus
from a litter of size s, whose dam was exposed to dose d,
given that a predisposing change occurred in its litter
environment.
As an initial approach, Rai and Van Ryzin sug-
gested the one-hit model to represent k (d), the prob-
ability that the toxicant will produce a change in the
litter environment that can lead to a specific adverse
effect in the individual fetus. However, other models
may be used to represent this probability ofa litter effect.
The one-hit model assumes that a response can be
induced after a single susceptible target has been hit by
a single biologically effective unit of dose (4). The prob-
ability of this hit is taken to be proportional to the dose
level, i.e., Pr(hit) = (d, for some positive value of (. Ifthe
number of hits is assumed to follow the Poisson dis-
tribution (a distribution used for small numbers of
events or counts) with the parameter of the distribu-
tion (the mean number of hits) equal to (d, then the
probability of a response at dose d equals the probability
of at least one hit, which is one minus the probability
of no hits, or 1 -exp(-Pd). This version of the one-hit
model is often referred to as the linear nonthreshold
dose-response model since at low doses (small values of
fdi) the probability of a hit is approximately equal to Pd.
Background risk is incorporated into this model by
adding an intercept, oc, to the linear expression in the
exponent. The first component of the RVR model, the
probability of a predisposing effect on the litter envi-
ronment, is thus expressed as 1 - expl-(a + Pd) I. The
tendency of the one-hit model toward linearity at very
low doses produces higher estimates of risk, and hence
more conservative safe dose estimates than risk models
that have convex (concave upwards) shapes, such as
the probit model.
Rai and Van Ryzin expressed the second component
of the model as an exponential function, with the
exponent modified by (multiplied by) litter size, s.
Although it could be any function of dose, they chose
the exponent to be linear in dose, and again incor-
porated an intercept term, 01, to allow for a background
risk, i.e., the conditional risk of a fetal response in the
no-dose group. The exponent in the second component
is thus expressed as (-s(01 + 02d)), with the coefficient
02 indicating the importance of dose level in the
conditional risk to the fetus.
Since the second component of the model is also a
probability and cannot be greater than 1, it reduces the
primary probability, that of effect on litter environ-
ment, by modifying it through the influence of litter
size and dosage to obtain the risk to the individual
fetus. This formulation of the model, with the con-
straint that probability must be positive and no greater
than 1, does not allow increased litter size to increase
the risk to the fetus, but only to decrease the risk, or to
have no effect. The complete model is given as
P(d,s) = [1-exp{-(ca+f3d)}] exp{-s(01+02d)} [2]
This form of the model estimates the risk to the
individual fetus when the litter size is known. In
order to generalize the model across all observed litter
sizes, while maintaining the adjustment for litter size,
a theoretical distribution for litter size must be
postulated. The overall risk to the fetus at a specific dose
is then determined by integrating the risks for each
litter size at that dose over the assumed distribution of
litter sizes. This is similar to taking the weighted
mean ofthe risks for each litter size, with weights equal
to litter size frequencies based on the assumed dis-
tribution. The observed litter size frequencies for a
specific dose group are used to estimate the distribution
parameters atthat dose.
The litter size distribution that is incorporated into
this version of the model is the Poisson distribution
for counts, and in this case the counts are the numbers
of littermates. This model version assumes that the
Poisson distributions parameter, E(S), the expected
230DOSE-RESPONSE MODEL FOR DEVELOPMENTAL TOXICITY
(mean) litter size, changes with dose, but not linearly.
Instead, the expected litter size is assumed to have the
following nonlinear form in dose d
E(S) = 4lexp (-42d) [31
where the parameter°l is the expected litter size in the
controls, and the new parameter02 represents the effect
of dose on litter size. This formulation implies larger
litter sizes at lower doses if02 is estimated to be greater
than zero, and smaller litters if its estimate is negative.
When the appropriate integration (summation
here because litter size is a discrete variable) is carried
out, the final model for estimating individual pup
risk at dose dis
P(d) =
[1-exp{-(ac+jd)}] exp[-P1exp(-02d){1-exp(-(01+02d))1]
[4]
with the parameters, a, ,B 01, 0(2 p1, and 02 appropriately
constrained to ensure that neither of the two
component probability estimates is greater than 1 nor
negative. It can be seen that, while linear functions of
dose are employed in the exponents, the risk model
itself is nonlinear. If, instead of the one-stage model, a
multistage model were used for the first component
(the probability of a predisposing change in the litter
environment), then the dose function in the exponent
would itself be nonlinear. In the model as formulated
above, the background (d = 0) probability of distur-
bance in the litter environment is equal to 1-exp(-a).
The overall background risk is expressed as
P(O) = {1-exp(-a)lexp[-j{1-exp(0j)I] [5]
Thus, when exposure to the toxicant under study is
zero, as in the controls, this model still allows for a
nonzero probability of the predisposing litter distur-
bance and a nonzero conditional probability of an
adverse effect onthe fetus.
Parameter Estimation and
Hypothesis Tests
Estimation of the model parameters was done using
the maximum likelihood method that maximizes the
fit of the model to the actual data set and assumes a
binomial distribution for events within a litter, i.e.,
the number of affected fetuses out of a litter of size s.
Thus, in this model, the variable for litter size
functions in two capacities, one as a varying risk set
(subsample) size, and another as a covariate to repre-
sent differences among litters.
Hypotheses on the parameters are tested by the con-
ditional likelihood ratio test. In this version of the
model, the hypotheses test the degree of exponential
linearity of the dose effect in each of the two compo-
nents. Testing the hypothesis that 3 = 0 indicates
whether there is a relationship between dose and the
probability of litter disturbance. Technically, testing 02
= 0 indicates whether the relative advantage to the fetus
of being from a litter one size larger varies with dose.
Since the model is constructed on the assumption that
larger litter size is associated with reduced risk, this
test is an indirect way to investigate dose effect on
individual fetus risk, conditional upon a predisposing
change in litter environment. The parameters a and
01 could also be similarly tested to obtain information
on the significance of background risk, as described in
the previous section.
Estimation of Low-Risk Doses
Use of a mathematical model enables the estimation
of risk at any specified dose and the estimation of dose
for any specified risk, as well as the confidence limits
on the risk or dose estimates. In particular, a model
allows those low doses that are associated with very low
specified risks, such as 1 in 10,000, to be estimated, as
well as their lower 95% confidence limits. For their
model, Rai and Van Ryzin provide two different
methods for approximating the lower 95% confidence
limit on these low-risk doses: the first is dependent on
the distribution of litter sizes, and the second is not.
Both methods estimate the lower limit in terms of the
added risk over background, since this is the risk of
interest atlow doses.
In the first method, a low level of the added risk, t*,
is specified, say 10-4, and the following equation is
solved for d to obtain the estimated dose that will pro-
duce no greater added risk:
[61
with the maximum likelihood estimates of the
parameters substituted into P(d) and P(O). The vari-
ance of the estimated dose is obtained from the Infor-
mation matrix (the Information matrix is the nega-
tive inverse of the covariance matrix of the likelihood
function). The approximate lower 95% confidence limit
of the dose estimate is calculated by assuming that the
dose estimate is normally distributed.
The second method uses the fact that the first proba-
bility component of the model is actually an upper
bound on the model. P(d,s), the risk estimate for a fetus
from a litter of size s, decreases as litter size s increases,
and thus has a maximum value when s = 0, i.e., where
P(d,s) = P(d,O) = X (d), its upper bound. Thus, a con-
servative method for interpolating to a low-risk dose is
to consider the added risk over background only for
the first component probability. The formulation is
then t(d) = k(d) - k(0), which, for the one-hit model, is
231
,A* = 74d)
= P(d) P(O)
= 10-4FAUSTMAN ETAL.
approximately equal to (1d)exp(-o). The equation to be
solved ford, the low-risk dose in this case, is:
7t* = ir(d) = (f3d) exp(-ac) = 10-4 [71
The approximate variance of the estimated dose is
derived by taking its natural logarithm and applying
the formula for the variance of a ratio. Again, the com-
ponent variances are obtained from the Information
matrix based on the likelihood function. The approx-
imate lower 95% confidence limit is calculated for the
estimated low-risk dose by assuming that its logarith-
mic transform is normally distributed.
Application of the Model to Data
The RVR model has the flexibility to allow the end
point data to vary in accordance with the study design
and the research goal. It can assess dose-response rela-
tionships when adverse effects are taken to be non-live
implants, total or specific malformations, total adverse
outcomes, etc. It requires only that the appropriate
measure of litter size be used in each case, e.g., total
implantations for non-live implants; number of live
fetuses at term for malformations.
The RVR model in the version described above was
applied to several data sets from standard Segment II
developmental toxicity studies conducted by Research
Triangle Institute under contract to the National Tox-
icology Program (NTP). Chemical data sets modeled
were diethylhexyl phthalate (DEHP), mice (5) and rats
(6); ethylene glycol (EG), mice (7) and rats (8); tri-
ethylene glycol dimethyl ether (TGDM), mice (9) and
rabbits (10); diethylene glycol dimethyl ether
(DYME), mice (11) and rabbits (12); and theophylline
(THEO), mice (13) and rats (14). Data from a postnatal
study on nitrofen exposure to rats during
organogenesis were obtained from the Health Effects
Laboratory, U.S. EPA, Research Triangle Park, NC
(15).
In all the NTP data sets analyzed, the risk for two
categories of end points were considered: (a) non-live,
i.e., the total number of deaths and resorptions out of
the total number of implantations; and (b) mal, i.e., the
number of fetuses with at least one malformation out of
the total number of live fetuses. For the nitrofen data
(perinatal toxicity study), a single adverse outcome
was analyzed, i.e., the sum of the pre- and perinatal
deaths and the cyanotic pups at birth out of the total
number of implantations.
Results of Model Application
The model-estimated risk probabilities and their two
components are displayed in Table 1 for both nonlive
and mal in 10 ofthe data sets. The second column gives
the first component, i.e., the probability of change in
the litter environment. The next column gives the
second component, i.e., the probability that a fetus
displays the effect, given that the precipitating change
in the litter environment has occurred. The last
column is the overall or final (unconditional) prob-
ability of a fetus response and is the product of the two
component columns. It should be noted that the two
component risk probabilities are not determined in-
dependently, since the four parameter estimates upon
which they are based are jointly (simultaneously)
estimated in the process of maximizing the likelihood
function.
In Table 1 a pattern emerges among these studies in
which the risk to the litter environment tended to
increase in small increments as dose increased, but the
conditional risk to an individual litter member
increased in sizeable increments only at the top dose(s).
While the overall risk to the fetus tended to combine
these two probability patterns into one with more
moderate, but still notable, increases at the highest dose,
in individual studies the final fetus risk pattern was
closer either to the litter risk (e.g., EG, mice, mal) or to
the conditional fetus risk (e.g., TGDM, mice, nonlive).
The actual size of the final risk is a product of both
components and will not necessarily be close to either
one. However, one can think of the primary probability
as being the risk to the litter environment, which is
then modified (decreased) by the conditional proba-
bility of risk to an individual fetus in that litter.
The results of fitting the Rai and Van Ryzin model
to these data sets can be observed more easily when
graphed. Figures la-k show three point estimates at
each dose in each study for the two end points modeled:
one is the RVR model estimate of fetus risk, the second
is the average proportion per litter of affected
littermates, and the third is the average percentage of
litters with at least one member affected. The second and
third estimates are from calculations presented in the
original reports on these studies (3-13). All three are
estimates of risk probabilities. The first two estimate in
different ways the probability at a specific dose that an
individual fetus is affected. The third estimates the
probability at a specific dose that a litter is affected with
the criterion being that at least one litter member is
affected.
The point estimates of risk from the model are
connected in the graphs in order to represent the
continuous property of the RVR model. However, the
actual graph of the model would be represented more
accurately by a curved line of the continuous function
expressed byP(d). Since the first two point estimates
named previously (RVR model estimate and average
proportion per litter of affected littermates) express the
risk to an individual fetus, and the third (average
percentage of litters with at least one member affected)
reflects the risk to a litter, the third point is markedly
higher than the other two because it represents a broad
range of risk scenarios for any one affected litter, from
only one affected fetus to the entire litter affected. Only
when every affected litter contains no unaffected fetuses
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Table 1. Model-estimated risk probabilities.
Probability of Overall
predisposing change Conditional probability
Data seta/ in litter probability of of fetus
dose, mg/kg environmentb fetus effectc effectd
0.1879
0.2419
0.3168
0.5616
0.9999
0.1351
0.1789
0.2408
0.4486
0.8314
0.0944
0.1520
0.2379
0.5147
0.9139
0.0210
0.0718
0.1550
0.4406
0.8599
0.0262
0.0770
0.2210
0.4497
1.0000
0.0122
0.0362
0.1046
0.2137
0.4773
0.1877
0.3361
0.5485
0.7371
1.0000
0.0070
0.0126
0.0205
0.0276
0.0375
0.3716
0.3988
0.4269
0.4858
0.1063
0.1285
0.1523
0.2043
0.6523
0.7333
0.8158
0.9835
0.3820
0.4879
0.6214
1.0000
0.0939
0.1652
0.2813
0.7441
0.1659
0.2077
0.2600
0.4074
1.0000
0.0355
0.0648
0.1110
0.2739
0.9632
0.0030
0.1533
0.3030
0.5931
0.0422
0.0644
0.0949
0.1930
0.0145
0.1032
0.2345
0.7197
0.0464
0.0644
0.0883
0.1606
0.4907
0.0020
0.0258
0.0684
0.2311
0.9383
(Continued on next page)
0.7187
0.7396
0.7602
0.7988
0.8314
0.2220
0.4725
0.6517
0.8560
0.9410
0.4468
0.4704
0.4735
0.4753
0.4773
0.0373
0.0374
0.0374
0.0374
0.0375
0.2860
0.3223
0.3568
0.4205
0.0046
0.2090
0.3714
0.6031
DEHP, mice
Non-live
0
44
91
191
292
Mal
0
44
91
191
292
DEHP, rats
Non-live
0
357
666
856
1055
Mal
0
357
666
856
1055
EG, mice
Non-live
0
750
1500
3000
Mal
0
750
1500
3000
EG, rats
Non-live
0
1250
2500
5000
Mal
0
1250
2500
5000
DYME, mice
Non-live
0
62.5
125
250
500
Mal
0
62.5
125
250
500
0.1105
0.1319
0.1528
0.1930
0.1547
0.6248
0.8335
0.9672
0.2797
0.3103
0.3395
0.3943
0.4907
0.0564
0.3981
0.6160
0.8438
0.9741
2833FAUSTMAN ETAL.
Table 1. Model-estimated risk probabilities (continued).
Probability of Overall
predisposing change Conditional probability
Data seta/ in litter probability of of fetus
dose, mg/kg environmentb fetus effectc effectd
DYME, rabbits
Non-live
0
25
50
100
175
Mal
0
25
50
100
175
TGDM, mice
Non-live
0
250
500
1000
Mal
0
250
500
1000
TGDM, rabbits
Non-live
0
75
125
175
250
Mal
0
75
125
175
250
THEO, mice
Non-live
0
282
372
396
Mal
0
282
372
396
Nitrofen, rats
Deaths and cyanotic
0.000
0.150
0.460
1.390
4.170
12.500
25.000
0.1249
0.2182
0.3015
0.4424
0.6023
0.1293
0.2882
0.4182
0.6112
0.7876
0.6179
0.6822
0.7357
0.8172
0.0538
0.0689
0.0838
0.1128
0.3856
0.4168
0.4367
0.4559
0.4835
0.2317
0.3767
0.4578
0.5283
0.6173
1.0000
1.0000
1.0000
1.0000
0.0122
0.0199
0.0224
0.0230
0.1719
0.1745
0.1799
0.1959
0.2419
0.3646
0.5124
0.4137
0.4469
0.4838
0.5696
0.7378
0.0517
0.0975
0.1459
0.2520
0.4444
0.2574
0.3018
0.3517
0.4706
0.7018
0.0333
0.0870
0.1471
0.2876
0.5527
0.1350
0.1474
0.1606
0.1898
0.0834
0.1005
0.1182
0.1551
0.0271
0.0627
0.1505
1.0000
0.0015
0.0043
0.0126
0.1128
0.2611
0.3968
0.5204
0.6787
1.0000
0.1007
0.1654
0.2273
0.3094
0.4835
0.3237
0.4938
0.6265
0.7708
1.0000
0.0975
0.2050
0.2586
0.2752
0.0750
0.1860
0.2868
0.4073
0.6173
0.0975
0.2050
0.2586
0.2752
0.2379
0.6652
0.9177
1.0000
0.0029
0.0133
0.0205
0.0230
0.4223
0.4245
0.4292
0.4435
0.4890
0.6532
1.0000
0.0726
0.0741
0.0772
0.0869
0.1183
0.2381
0.5124
aDEHP, diethylhexyl phthalate; EG, ethylene glycol; DYME, diethylene glycol dimethyl ether; TGDM, triethyleneglycol dimethyl ether; THEO,
theophylline.
bA(d) = 1 - exp [- (a + Pd)].
cP[d,s; A(d)]=exp [-4 exp (-02d) {1-exp(-(01+02d))}].
dP(d) =A(d) x P[d,s; A(d)].
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FIGURE 1. (a-l) Show, for the end points nonlive (total prenatal deaths) and mal (malformations), a graphic comparison of the NTP study risk
estimates versus the Rai and Van Ryzin model risk estimates. (k) Shows the same comparison for the perinatal toxicity end point in the nitrofen
study. (-) Percentage of litters with at least one affected fetus; (U) average percentage of affected fetuses in a litter, as calculated in the NTP
studies. (0) Rai and Van Ryzin model risk predictions, connecting lines indicate the continuous nature of the modeled dose-response
relationship.
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two components ofthe model in the shape ofthe overall
model. For example, the study of EG in mice (Table 2)
shows no dose relationship in either litter effect or fetus
effect for the non-live end point, but significant dose
relationships in both components for the mal end
point. Similarly, Figure lb shows a strong dose-
response relationship in the overall model for mal, but
a weaker one for non-live. In the DEHP studies, Figure
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ld (rats) shows a much weaker trend with dose in
point. Similarly, Figure la shows a weak dose-response
relationship for non-live and a strong one for mal. The
study of EG in rats (Table 2) shows a significant dose
relationship in litter and fetus risk for the mal end
point, but only in the fetus risk for the non-live end
general than does Figure Ic (mice). This is also
reflected in Table 2, where the modeled dose relation-
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ship in litter and fetus risk for both end points in the
DEHP studies was significant in mice, but only in the
fetus risk for the non-live end point in rats.
Comparison of Low-Risk Dose
Estimates with the NOAEL/UF
Approach
Interpolations were done as part of this analysis in
order to compare the model dose estimates at very low
risks with the results of the method currently in use,
i.e., the NOAEL/UF approach. The model-estimated
low-risk doses were determined for a risk of 1 in 10,000
by two methods described earlier. A comparison of
doses that are estimated to be acceptable by specified risk
standards is given in Table 3 for the non-live end point
and in Table 4 for malformations. The NOAEL in each
case was determined from the original study reports to
be the highest experimental dose tested that did not
produce a statistically significant (p = 0.05) adverse
effect when compared to controls. The NOAELs were
then divided by a UF of 100, i.e., a 10-fold factor for
interspecies variability and a 10-fold factor for within-
species variability (16). In those cases when all doses
showed a statistically significant effect compared to
controls, the lowest dose was considered the lowest-
observed-adverse-effect level (LOAEL) and was divided
by an additional factor of 10.
The model-estimated doses were within an order of
magnitude or were no more than one order of mag-
nitude smaller than the uncertainty factor-adjusted
NOAELs in all but three cases: TGDM mice, non-live by
method 2; DYME mice, mal by method 2; and TGDM
rabbits, mal by both methods. In the case of TGDM
mice, non-live, there was no significant increase by
pairwise comparison at any dose tested, so that it was
not possible to determine a NOAEL accurately.
However, this was not the case for the DYME mice, mal
end point. The greatest discrepancy was between the
NOAEL/UF and the model-estimated low risk doses for
TGDM rabbits, mal. In this case, it can be seen from the
graph (Fig. if) thatthe dose chosen as the NOAEL (125
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is the individual fetus risk equal to the litter risk. To
the extent that only a portion of fetuses in a litter are
affected, the risk probabilities between litter and fetus
will diverge.
The graphs show that the model reflected strong
dose-response relationships, such as those observed for
both categories of end points, non-live and mal (Fig. ic,
f,g, and h), for mal only in ethylene glycol-treated mice
and rats (Figs. la and b), and for perinatal toxicity in
nitrofen-treated rats (Fig. lk). The model also reflected
the shallow dose-response relationships observed for
nonlive in ethylene glycol-treated mice and rats (Figs.
1a and b), for mal in DEHP-treated rats and
theophylline-treated mice, and for both responses in
mice following exposure to TGDM (Fig. le). Figure lj
shows examples of instances where there was no dose-
response relationship and the data could not be
modeled.
Goodness-of-Fit Test
The test proposed by Rai and Van Ryzin for
determining the fit of the model to any particular set of
data is appropriate only for large sample sizes. Their
suggested remedy, to group litters of different but
similar sizes, was not considered to be satisfactory, and
a different test that did not require large samples was
used. This goodness-of-fit test is based on the pure error
obtained from replications, using the litters of the same
size from the same dose group as the replicates. The
difference between the total sum of squares of residuals
(the deviations of the data points from their model
predictions) and the replicates' sum of squares
provides the sum of squares due to lack of fit. The ratio
of the mean square due to lack offit to the mean square
for pure error has an F distribution with the
appropriate degrees offreedom.
Of the 19 data sets, this version of the RVR model
was found to fit 15; the fit for each of the remaining 4
data sets was rejected at the p = 0.01 significance level.
These data sets were the nonlive response for DEHP
mice and EG rats, and the mal response for TGDM
rabbits and THEO mice (a data set with minimal dose
response). However, the results of the model evalua-
tions for these four data sets are included for com-
parison.
Further study of these data sets with respect to the
deviations between the observed data points and their
model predictions could provide insight into possible
alternate versions of the RVR model that would better
represent these four dose-response relationships. Inter-
active investigation of a hypothesized model and its
actual fit to a specific data set can work toward both
model improvement and increased understanding of
the information in the data.
Hypothesis Tests of Dose-
Response Relationships
The results of testing the significance of the
parameters that estimate the relationship, as modeled,
between the risk probabilities and dose in these data sets
are given in Table 2. For the RVR model, this involves
testing whether the parameters 3 and 02 could be sig-
nificantly different from zero, with the significance
level set atp = 0.05. If a significant difference from zero
is found, it means that a relationship with dose is
likely to exist. But if a significant difference from zero
is not found, it means only that the relationship
between dose and risk that is postulated in the model
could not be confirmed by the data. There still may
exist a dose-response relationship in the data that was
not adequately modeled.
InTable 2, the tests ofdose-related effects are given for
four risk estimates: (a) the component ofthe model that
estimates risk of predisposing change in the litter
environment; (b) the model component that estimates
conditional risk to the individual fetus; (c) the risk to
the litter as estimated by the proportion oflitters with at
least one affected fetus; and (d) the risk to the fetus as
estimated by the average proportion affected per litter.
The last two estimates are from the original study
reports and are based on the results oflineartrend tests.
The closest agreement in identification of a
significant dose-related effect was between the two
estimates of individual fetus risk, i.e., the model
estimate and the mean proportion affected per litter. In
onlythree caseswas there adisagreementbetween these
estimates, i.e., non-live for EG mice, mal for DEHP rats,
and mal for THEO mice. In all three of these cases the
model-defined dose-response relationship was not
found to be significant, although there was a slight
though sufficient dose-related increase that could be
identified by the linear trend test in the original study
report. However, in none ofthese cases did the pairwise
comparisons show a statistically significant increase
in response above control values for any of the doses
tested.
When P is not significantly different from zero, but
02 is, the dose relationship is indicated to be stronger
for the individual fetus than it is for the litter
environment. This is seen clearly for the non-live end
point in the modeled studies. A significant dose
relationship was not often found in the modeled risk to
litter environment (,B) for the non-live end point. In
five cases where the dose relationship was significant
in the conditional risk to the fetus (02), it was non-
significant in the risk to the litter environment. This
may be related to the fact that the background incidence
of prenatal deaths is relatively high, and the dose-
related effect must be relatively strong to represent a
significant increase. For the mal end point, in every
case except one (TGDM mice), when the dose relation-
ship was significant in the conditional risk to the
fetus, it was also significant in the risk to the litter
environment. Conversely, this may reflect the fact that
the background incidence of malformations is rela-
tively low so that a relatively moderate increase with
dose may be found to be significant.
Comparisons of the results in Table 2 with Figures
la-k illustrate the roles ofthe dose relationships in the
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Table 2. Tests of dose-response relationships.a
Compoundb
EG
DEHP
TGDM
DYME
THEO
Species
Mice
Rats
Mice
Rats
Mice
Rabbits
Mice
Rabbits
Mice
Rats
End point
Non-live
Mal
Non-live
Mal
Non-live
Mal
Non-live
Mal
Non-live
Mal
Non-live
Mal
Non-live
Mal
Non-live
Mal
Non-live
Mal
Non-live
Mal
Dose effect
on litter
environmentc
NS
S
NS
S
S
S
NS
NS
NS
NS
NS
S
NS
S
S
S
NS
NS
NS
NS
Dose effect
on fetus
NS
S
S
S
S
S
S
NS
NS
S
S
S
S
S
S
S
S
NS
_e
_e
% Litters
affectedd
S
S
S
S
ND
ND
ND
ND
NS
NS
NS
NS
S
S
S
S
NS
S
NS
NS
% Affected
per litterd
S
S
S
S
S
S
S
S
NS
S
S
S
S
S
S
S
S
S
NS
NS
Nitrofen Rats Death, cyanotic S S ND ND
ap < 0.05.
bDEHP, diethylhexyl phthalate; EG, ethylene glycol; DYME, diethylene glycol dimethyl ether; TGDM, triethylene glycol dimethyl ether; THEO,
theophylline.
CNS, nonsignificant; S, significant.
dTaken from results of linear trend tests in original study reports; ND = not done.
'Model parameters were not estimable due to absence of consistent relationship between dose and response.
Table 3. RVR model-estimated doses for excess risk of 1/10i compared with NOAELs adjusted by uncertainty factor of 100.
Model-estimated dose
Non-live, NOAEL/100 for excess risk of 1/104, mg/kg/day
Compound Species % Response % Litters (lower 95% CI)b
testeda tested per litter with response Method 1 Method 2
EG Mice > 30c > 30' 3.5 2.0
(0) (3.4 x 10-2
Rats 25 > 50' 6.7 5.8
(0) (2.9 x 10-')
DEHP Mice 9.1 x 10' 9.1 x 10-ld 1.2 x 10- 2.0 x 10-l
(8.4 x 10-2) (9.7 x 10-4)
Rats 8.56 8.56d 2.9 10.0
(1.5) (0)
TGDM Mice > 10c > 10' 1.5 3.6 x 10-
(0) (1.8 x 10-3)
Rabbits 1.75 1.75 1.5 x 10- 2.3 x 10-
(1.1 x 10-') (2.7 x 10-3)
DYME Mice 1.25 2.5 4.0 x 10-1 2.0 x 10
(1.4 x 10') (1.9 x 10-2)
Rabbits 5 x 10- 5 x 10- 5.6 x 10-2 2.5 x 10-2
(0) (1.3 x 10-2)
aDEHP, diethylhexyl phthalate; EG, ethylene glycol; DYME, diethylene glycol dimethyl ether; TGDM, triethylene glycol dimethyl ether.
bDoselevel calculatedbymodel at an excessriskof10-4. The values inparentheses arelower95% confidence limits onthe dose estimate. Methods
1 and 2 refer to methods used to do the low-dose interpolation. See text for specific information.
cValue here is highest dose tested; no statistically significant LOAEL was found. True NOAEL could be much higher.
dTests ofsignificance for percentage oflitters with response were not conducted in the original study. Values here are taken from tests done on
the number oflitters with response.
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Table 4. RVR model-estimated doses for excess risk of 1/104 compared with NOAELs adjusted by uncertainty factor of 100.
Model-estimated dose
Mal, NOAEL/100 for excess risk of 1/104, mg/kg/day
Compound Species % Response % Litters (lower95% CI)b
testeda tested per litter with response Method 1 Method 2
EG Mice 7.5 x 10-Ic 7.5 x 10 c 5.0 x 10' 3.3 x 10-
(0) (1.9 x 10-1)
Rats 12.5 1.25c 1.7 1.8 x 10-'
(0) (6.5 x 10-2)
DEHP Mice 4.4 x 101 4.4 x 10- d 1.1 x 10l 1.5 x 10-2
(0) (6.3 x 10-)
Rats > 10.55' > 10.55 8.6
(4.6)
TGDM Mice 5.0 5.0 15.1 1.6
(°) (1.6 x 10-
Rabbits 1.25 1.25 8.6 x 10-2 4.7 x 10-2
(2.1 x 10-) (2.1 x 10-2)
DYME Mice 1.25 1.25 3.8 x 10- 1.5 x 10-2
(0) (6.5 x 10-3)
Rabbits 5.0 x 10' 5.0 x 10-1 4.9 x 10-2 1.4 x 10-2
(0) (7.1 x 10-)
aDEHP, diethylhexyl phthalate; EG, ethylene glycol; DYME, diethylene glycol dimethyl ether; TGDM, triethylene glycol dimethyl ether.
bDose level calculated by model at an excess risk of 10-4. The values in parentheses are lower95% confidence limits on the dose estimate. Methods
1 and 2 refer to methods used to do the low-dose interpolation. See text for specific information.
cValue here is lowest dose tested; and all doses were statistically significant when compared to control values. This value is assumed to be the
LOAEL and an additional 10-fold UF (total of 1,000) was used.
dTests ofsignificance for percentage oflitters with response were not conducted in the original study. Values here are taken from tests done on
the number of litters with response.
eValue here is highest dose tested; no statistically significant LOAEL was found. True NOAEL could be much higher.
fInsufficient dose-response relationship.
mg/kg/day) was associated with a response level
(percentage affected per litter) that was low compared to
the next lower dose and was also much lower than the
model estimate. Ifthe response level had been as high as
expected, based onthe incidence atadjacent doses, then a
lower NOAEL would have been chosen that, when
divided by a UF of 100, would be closer to the model-
estimated low risk dose.
Thus, based on comparisons with the RVR model,
the current approach for developmental toxicity risk
assessment (NOAEL/UF) in most cases results in the
identification ofacceptable exposure levels that compare
with model dose estimates for 103 to 104 excess risk.
This is not surprising, as the NOAEL is likely to be in
the response range of 1 to 10% and a 100-fold UF would
reduce the riskto between 1 in 1,000to 1 in 10,000 (17).
Summary
Preliminary studies have been conducted to
evaluate the applicability of a dose-response model for
dichotomous responses in developmental toxicity. The
flexibility of the RVR model has been discussed, as well
as the potential extension of this model to reflect
mechanistic aspects of biological processes. We have
shown that multiple hypothesis testing is possible with
this model to determine the relationships of risk to
dose. An important strength of this model is that low-
dose interpolation is carried out using information
from individual fetuses and litters. In addition, con-
fidence limits can be calculated both for the estimated
risk at any dose, and for the estimated dose at any
specified risklevel.
Our studies have shown that the RVR model as
described here closely models the data from standard
developmental toxicity studies for the proportion of
non-live implants and the proportion of malforma-
tioned fetuses. Although the model may not account for
all the variation due to litter differences (18), it uses
litter size to account for a portion. Future direction for
these evaluations include characterization of
additional data sets, the addition of covariates other
than litter size, the incorporation of intralitter
correlation, and the application of other modeling
functions, e.g., multihit, multistage, to express litter or
individual fetus risk.
Portions of this work were presented at the Annual Meeting of the
Teratology Society, Palm Springs, CA, June 1987 [Teratology 35:67A
(1987)]. The views in this paper are those of the authors and do not
necessarily reflect the views or policies of the U.S. Environmental
ProtectionAgency.
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